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Oronasal fistula development is a compli-cation after cleft palate surgery, with an incidence of 3.9 to 4.0 percent.1,2 Further 
causes are trauma, tumors, infections, or nasally 
administered drugs, such as cocaine.3–6 Patient 
discomfort is caused by saliva and food inflow into 
the nasal cavity, velopharyngeal insufficiency, and 
hypernasality of speech.7–9
Numerous techniques for oronasal fistula repair 
have been described, including tongue flaps,10–14 
mastoid fascia grafts,15 auricular cartilage transplan-
tation,16 bone grafts,17 distraction osteogenesis,18 
and free flap transfer.19,20 However, no standard 
techniques have been presented, and up to 65 per-
cent of oronasal fistulas are reported to reappear.21 
This might be attributable to local tissue condi-
tions, with scarring and restricted motility making 
tension-free surgical intervention difficult. Current 
research is aimed at developing tension-reductive 
techniques.
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Background: Oronasal fistulas are a frequent complication after cleft palate 
surgery. Numerous repair methods have been described, but wound-healing 
problems occur often. The authors investigated, for the first time, the suitabil-
ity of multilayered amniotic membrane allograft for fistula repair in a labora-
tory experiment (part A), a swine model (part B), and an initial patient series 
(part C).
Methods: In part A, one-, two-, and four-layer porcine and human amniotic 
membranes (n = 20 each) were fixed in a digital towing device and the 
force needed for rupture was determined. In part B, iatrogenic oronasal fis-
tulas in 18 piglets were repaired with amniotic membrane allograft, autofetal 
amniotic membrane, or small intestinal submucosa (n = 6 each). Healing 
was evaluated by probing and visual inflammation control (no/moderate/
strong) on postoperative days 3, 7, 10, and 76. Histological analysis was per-
formed to visualize tissue architecture. In part C, four patients (two women 
and two men, ages 21 to 51 years) were treated with multilayered amniotic 
membrane allograft.
Results: In part A, forces needed for amniotic membrane rupture increased 
with additional layers (p < 0.001). Human amniotic membrane was stronger 
than porcine membrane (p < 0.001). In part B, fistula closure succeeded in all 
animals treated with amniotic membrane with less inflammation than in the 
small intestinal submucosa group. One fistula remained persistent in the small 
intestinal submucosa group. In part C, all fistulas healed completely without 
inflammation.
Conclusions: Amniotic membrane is an easily available biomaterial and can 
be used successfully for oronasal fistula repair. The multilayer technique 
and protective plates should be utilized to prevent membrane ruptures.  
(Plast. Reconstr. Surg. 132: 172, 2013.)
CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, V.
From the Department of Oral and Maxillofacial Surgery, 
Technische Universität München; Department of Oral and 
Maxillofacial Surgery, General Hospital of Linz; Clinic 
for Swine, Faculty of Veterinary Medicine, Ludwig-Maxi-
milians-University of Munich; Department of Oral and 
Maxillofacial Surgery, Southampton University Hospital 
NHS Foundation Trust; and Department of Plastic Surgery, 
Burn Unit, BG University Hospital Bergmannsheil, Ruhr 
University Bochum.
The first two authors contributed equally to this study.
Received for publication December 17, 2012; accepted January 
28, 2013.
Repair of Oronasal Fistulae by Interposition of 
Multilayered Amniotic Membrane Allograft
PEDIATRIC/CRANIOFACIAL
Volume 132, Number 1 • Oronasal Fistula Repair
173
In 2006, Kirschner et al.21 introduced the use 
of human acellular dermal matrices for oronasal 
fistula repair. The authors observed the ingrowth 
of fibrovascular tissue and complete fistula closure 
in nine patients.
Another biomaterial suitable for oronasal fis-
tula repair might be amniotic membrane, which is 
easily available and reasonably priced with regard 
to its harvesting and processing to a medical prod-
uct (e.g., testing for viral infections of the donors 
and cryoconservation). Amniotic membrane is the 
inner layer of the fetal membranes and has been 
investigated as an alternative biomaterial for vari-
ous purposes in reconstructive surgery since its 
initial description as a material suitable for trans-
plantation in 1910.22 It offered new perspectives, 
for example, in the treatment of burn wounds.23 
Interest in human amniotic membrane diminished 
as a consequence of emerging awareness of human 
immunodeficiency virus and the fear of virus trans-
mission in the 1980s. The end of the 1990s saw 
the establishment of new methods for the process-
ing and long-term storage (such as cryoconserva-
tion) of human amniotic membrane, and its use 
in reconstructive surgery became popular again.24 
However, the material is thin and lacerable, and its 
use in the oral cavity is challenging (e.g., because 
of forces caused by the tongue and food particles).
We recently investigated the suitability of xenog-
enous human amniotic membrane for the repair 
of oronasal fistula in a porcine model and obtained 
promising results.25 The aim of the present study 
was to expand our knowledge of this material as 
follows: (1) by evaluating the adequacy of the ten-
sile strength of human and porcine amniotic mem-
brane when arranged in the multilayer technique; 
(2) by evaluating amniotic membrane allograft 
for oronasal fistula repair in a porcine model and 
investigating possible advantages of autofetal amni-
otic membrane (i.e., the “autologous” amniotic 
membrane of a fetus harvested at its birth) (as a 
control, a resorbable, extracellular matrix scaffold 
material, termed “small intestinal submucosa,” was 
also evaluated); and (3) by transference to clinical 
practice in an initial small series of patients.
METHODS
Porcine and Human Amniotic Membrane
Experiments on animals were conducted in 
accordance with German governmental regula-
tions for animal welfare and with approval of 
the District Council (no. 55.2-1-54-2531-183-09; 
April 26, 2010). Porcine amniotic membrane was 
harvested during porcine cesarean delivery car-
ried out under general anesthesia, in the Clinic 
for Swine of Ludwig-Maximilians-University 
Munich. The membranes were separated from 
the piglets on their removal from the uterus 
under sterile conditions (Fig. 1), transferred to 
a sterile laminar flow hood (Herasafe; Kendro, 
Langenselbold, Germany), cut into 5 × 5-cm 
pieces, and applied to nitrocellulose sheets 
(Raucocel; Lohmann-Rauscher, Rengsdorf, Ger-
many). Each sheet was stored in a 50-ml sterile 
tube (Falcon; BD Biosciences, San Jose, Calif.) 
containing medium for cryoconservation consist-
ing of 250 ml of glycerin, 250 ml of Dulbecco’s 
Modified Eagle Medium (JR Scientific, Wood-
land, Calif.), 5 ml of penicillin/streptomycin 
solution, and 5 ml of amphotericin B solution 
(Merck, Darmstadt, Germany). The tubes were 
stored at −80°C and thawed for 30 minutes before 
usage in a 28°C water bath.
The study protocols for the use of human 
amniotic membrane in human patients were 
approved by the District Council and the local 
ethics committee (no. 3071/10; February 1, 2011). 
Operations were carried out in accordance with the 
Declaration of Helsinki. All patients gave written 
informed consent. Human amniotic membrane 
allografts were fabricated in cooperation with the 
Red Cross Transfusion Service of Upper Austria, 
Linz, Austria, as a certified medical product at a size 
of 4 × 4 cm. This size was determined in unpublished 
internal studies to ideally meet the requirements 
of reconstructive surgery in the oral cavity. 
Agglutination tests were performed for human 
immunodeficiency virus (anti-HIV), hepatitis C 
(anti-HCV), hepatitis B (anti-HBc, HB-Ag), and 
Fig. 1. Harvest of porcine amniotic membrane. Careful separa-
tion of the membrane from the piglet is carried out under sterile 
conditions.
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cytomegalovirus (anti-CMV-IgG/-IgM); Treponema 
pallidum hemagglutination and enzyme-linked 
immunosorbent assay tests were performed for 
syphilis; and polymerase chain reaction tests were 
performed for human immunodeficiency virus, 
hepatitis C  virus, and human papilloma virus.
Part A: Laboratory Experiment
Uniaxial forces needed for the rupture of one-
layer, two-layer, and four-layer human and porcine 
amniotic membranes were evaluated by fixing 
the membranes on a standardized square field 
(3 × 3 cm) in a digitally controlled towing device 
(model 100kN; Zwick, Ulm, Germany) (Fig. 2). 
Computer software determined the maximal 
force applied until rupture. The first test series 
consisted of 20 repeats for each one-layer, two-
layer, and four-layer porcine membrane. In the 
second series, the experiment was repeated with 
human amniotic membrane.
Statistical Analysis of Laboratory Experiment
IBM SPSS 19.0 software (SPSS, Inc., Chicago, 
Ill.) was used. Differences with respect to the 
forces needed for membrane rupture were ana-
lyzed by using the Mann-Whitney U test. All p val-
ues are given as two-tailed with a local significance 
level of 5 percent.
Part B: Animal Experiment
Animals and Defect Preparation
Twenty-four 8-week-old piglets (“Schwaebisch 
Haellische” × “Pietrain” hybrids, 22 to 32 kg; 
kept according to the international principles 
of laboratory animal care) were used. All were 
born by cesarean delivery from the same dam 
in the Clinic for Swine of Ludwig-Maximilians-
University, Munich. Their amniotic membrane 
was harvested and stored as autofetal amniotic 
membrane. Amniotic membrane allografts were 
collected from another dam. Water and food were 
given freely. Oronasal fistulas were produced 
under general anesthesia. To induce anesthesia, 
10 mg/kg body weight ketamine (Ursotamin; 
Serum-Werk, Bernburg, Germany) and 2 mg/
kg azaperone (Stresnil; Janssen-Cilag, Neuss, 
Germany) were administered intramuscularly. 
Animals were intubated, and anesthesia was 
maintained with 1 to 2 percent isoflurane 
(Isoba; Intervet, Unterschleissheim, Germany) 
and 3 to 5 liters/minute oxygen. Piglets were 
placed on their back. Silicon dental casts of the 
palates were taken before fistulas were made 
in order to manufacture individual protection 
plates for coverage of the defects after repair. 
The plates were manufactured in the Laboratory 
of the Technische Universität München and 
consisted of polymethylmethacrylate. In each 
piglet, a full-thickness defect in the mid–hard 
palate of ~15 mm in diameter was produced 
with a biopsy punch and subsequent water-
cooled osteotomy of the hard palate (Fig. 3). 
The nasal septum and edges of the bony palate 
were rongeured beyond the mucosal edges to 
allow for re-epithelialization at the periphery 
of the defects. Fistulas matured for 2 weeks. 
After this time, all fistulas were persistent and 
re-epithelialized at their margins.
Fistula Repair
Six animals were randomly selected to have 
their fistulas repaired with allografts of five-
layer amniotic membrane, six were treated with 
five-layer autofetal amniotic membrane, and 
six received small intestinal submucosa (Cook 
Group Inc., Bloomington, Ind.). Multilayered 
amniotic membrane was prepared as previously 
described.26 Grafts were interposed between the 
oral and nasal mucosa traversing the palatal fis-
tulas and sutured with polyglactin (Vicryl 4-0; 
Ethicon, Norderstedt, Germany) to the lateral 
edges of the mucoperiosteal bilateral flap cre-
ated according to the von Langenbeck tech-
nique (Fig. 4). Mucosal edges of the fistulas were 
Fig. 2. Uniaxial forces needed for rupture of one-, two-, and four-
layer human and porcine amniotic membrane were evaluated by 
fixing the membranes on a standardized test field with a width 
of 3 cm in a digitally controlled towing device (model 100 kN; 
Zwick, Ulm, Germany). The lower part of the image shows an 
example of a single-layer amniotic membrane adapted to the 
immobile metal plate of the machine. Membranes were sub-
sequently fixed to this plate by the addition of a second metal 
plate that was tightened against the first plate. The clamp in the 
upper half of the image was connected to the mobile part of 
the towing machine and pulled the membrane upward once 
the experiment was initiated. Forces needed until rupture were 
digitally recorded by computer software.
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not closed. The prefabricated protective plates 
were placed onto the palates and fixed with two 
13-mm screws in order to protect the transplants 
from mechanical damage (Fig. 5). Wounds were 
monitored by photodocumentation on postop-
erative days 3, 7, 10, and 76 under short sedation. 
They were cleaned of blood clots and food pel-
lets after removal of the palatal protective plates, 
which were refixed until they were ultimately 
removed on day 10. Wound monitoring involved 
the assessment of local inflammation by visual 
grading of the degree of redness around the fis-
tula (0 = none; 1 = moderate; 2 = pronounced) 
in the photographs, which were scored indepen-
dently by two blinded investigators. On day 76, 
the pigs were euthanized by sedation and intra-
venous administration of 45 mg/kg pentobarbi-
tal (Release; WdT, Garbsen, Germany). A final 
evaluation of the palates for remaining fistulas 
was performed with a probe, and the palates were 
removed and stored in formalin (3.7 percent) for 
microscopic analyses.
Histological Analysis
Samples were embedded in paraffin, and 
4-µm-thick sections were cut with a microtome 
(Hyrax M 55; Zeiss, Jena, Germany). Paraffin was 
extracted, and sections were stained with hema-
toxylin and eosin (Bio Optica, Milan, Italy) and 
analyzed with a microscope (AxioCam HRC; 
Zeiss). A closed oral and nasal epithelium with 
no fistula remnants and no signs of inflammation 
was regarded as the preferred result. Microscopic 
evaluation of the former defect region on day 76 
was carried out in order to confirm the clinical 
results with respect to closure of the oral epithe-
lium and to investigate the closure of the nasal 
defects and the presence of fistula tract rem-
nants on either side of the nasal septum. Accord-
ingly, two regions were evaluated in each animal, 
Fig. 3. Creation of iatrogenic oronasal fistula in the porcine palate. 
The animal had previously been intubated and placed on its back, 
with its tongue fixed to the lower jaw. The nasal septum is visible 
in the middle of the fistula. The marginal bone was removed in an 
undermining manner to allow epithelial growth over the defect 
margins from both the palatine and the nasal side of the fistula. 
In this manner, so-called critical-size defects were created, which 
showed no tendency for spontaneous healing. The defects were 
allowed to mature for 2 weeks and were subsequently repaired 
with multilayered amniotic membrane allograft, autofetal amni-
otic membrane, or small intestinal submucosa.
Fig. 4. Repair of iatrogenic oronasal fistula in a palate of a piglet using the von Langenbeck tech-
nique. (Left) Multilayered amniotic membrane is gently pulled through the incisions. (Right) The 
defect is covered with the transplant.
176
Plastic and Reconstructive Surgery • July 2013
resulting in a total of 12 areas of interest in each 
group. All stainings were produced in dupli-
cate and scored independently by two blinded 
investigators.
Part C: Clinical Trial
Four patients (two women and two men, 
ages 21 to 51 years) diagnosed with oronasal 
fistula of the hard palate were treated with 
multilayered amniotic membrane allografts 
(three in Munich, one in Linz). After defect 
preparation (removal of epithelium covering 
the fistula margins), amniotic membrane was 
fixed to the marginal oral epithelium (the 
fistula edges were freshened and the amniotic 
membrane was sewn to the nasal epithelium 
and subsequently to the oral mucosa) (Fig. 6, 
above). In none of the four patients could the 
defect be closed primarily or by local flaps. 
The von Langenbeck technique was not used 
in the patients in an attempt to reduce local 
tissue trauma. Protective plates were inserted 
for transplant protection in each patient (Fig. 6, 
center). The plates were produced as follows: 
dental models of the maxilla were produced by 
obtaining impressions in alginate (Palgat; 3M, 
Neuss, Germany) and filling them with gypsum. 
Fistulas were closed in the models with dental wax 
in order to simulate the postoperative situation. 
Polymethylmethacrylate plates (Biocryl; Scheu, 
Iserlohn, Germany) were heated and suctioned 
over the models in a vacuum device (Twinstar; 
Scheu), as recommended by the manufacturer. 
After the plates cooled down, their edges were 
shortened in order to avoid gingival trauma.
RESULTS
Part A: Laboratory Experiment
Single-layered human amniotic membrane 
exhibited a median tensile strength of 3.46 N 
until rupture (mean, 3.563 N; minimum, 1.23 
N; maximum, 6.04 N). Double-layered human 
Fig. 5. Fixed polymethylmethacrylate protective plate in the 
palate of a piglet to protect the transplants from mechanical 
damage caused by food or hay.
Fig. 6. Clinical use of amniotic membrane allograft for closure 
of a large oronasal fistula in a patient with a previously operated 
cleft palate. (Above) Amniotic membrane covering defect, fixed 
with sutures. (Center) Insertion of a protective plate. (Below) 
Postoperative situation with complete closure.
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membrane showed a median tensile strength 
of 8.455 N (mean, 9.283 N; minimum, 3.05 N; 
maximum, 16.25 N), which was higher than that 
of single-layered membrane (p < 0.001). Four-layer 
membrane exhibited a median tensile strength 
of 18.9 N (mean, 18.825 N; minimum, 11.29 N; 
maximum, 22.66 N), which was higher than that 
of double-layered membrane (p<0.001).
Single-layered porcine amniotic membrane 
exhibited a median tensile strength of 1.745 N 
until rupture (mean, 1.776 N; minimum, 0.8 N; 
maximum, 2.97 N). Double-layered porcine mem-
brane showed a median tensile strength of 3.82 
N (mean, 4.566 N; minimum, 1.52 N; maximum, 
9.41 N), which was higher than that of single-lay-
ered membrane (p < 0.001). Four-layered mem-
brane exhibited a median tensile strength of 9.94 
N (mean, 10.527 N; minimum, 6.04 N; maximum, 
17.03 N), which was significantly higher than that 
of double-layered membrane (p < 0.001).
Forces needed for the rupture of human 
amniotic membrane were higher than those 
needed for porcine amniotic membrane in each 
one-, two-, and four-layer technique (p < 0.001).
Part B: Animal Experiment
Clinical Course
All animals survived with no signs of illness. All 
oronasal fistulas showed marginal re-epithelializa-
tion and no tendency for spontaneous closure at 
2 weeks after their creation.
All oronasal fistulas treated with amniotic mem-
brane allograft and autofetal amniotic membrane 
showed similar wound healing. On day 7, amniotic 
membrane was no longer recognizable because of 
the overgrowth of granulating tissue and fibrin cov-
ering. Three of six fistulas in the allograft group 
and five in the autofetal group were completely 
closed on day 10. In both groups, all fistulas were 
completely closed and showed no signs of inflam-
mation on day 76 (Fig. 7). All animals in both 
groups showed moderate local redness on day 3; 
this increased in three cases in each group on day 
7. A single animal showed moderate local redness 
on day 10, and no inflammation was observed in 
any animal in either group on day 76 (Fig. 8). Thus, 
no difference in clinical course was observable 
between the animals treated with amniotic mem-
brane allograft or autofetal amniotic membrane.
No small intestinal submucosa was 
recognizable in animals treated with this material 
on the seventh postoperative day. One fistula 
was completely closed on day 10, and five of 
the six animals showed a completely closed oral 
epithelium on day 76. In the remaining case, a 
persistent fistula was found with a probe. Local 
redness was comparable with that of the amniotic 
membrane groups. Pronounced redness was seen 
in four animals on day 3 and one animal on day 7 
(five with moderate inflammation). Four animals 
exhibited moderate redness on day 10, and no 
signs of inflammation were observed on day 76.
Histologic Analysis
Histologic analysis confirmed the clinical 
observation of completely closed oral epithelium 
in all samples from both the allograft and the 
autofetal amniotic membrane groups. Two ani-
mals treated with allograft exhibited unilateral 
fistula tract remnants, and two exhibited bilateral 
remnants. Three cases of unilateral remnants 
were found in the autofetal group (Fig. 9), each 
with histologic signs of mild chronic inflamma-
tion on the nasal side. All fistula tract remnants 
were covered with respiratory epithelium.
All of the animals treated with small intestinal 
submucosa showed at least unilateral nasal fistula 
tract remnants. In four cases, remnants were found 
bilaterally, and in one case, the oral epithelium 
was not closed, indicating a persisting oronasal 
fistula. In all but one animal, signs of mild chronic 
inflammation were evident, and fibrosis occurred 
in four of these five cases. Table 1 provides an 
overview of the histological results and details 
regarding signs of inflammation and fibrosis.
Part C: Clinical Trial
All patients showed complete closure of the 
oral epithelium with no signs of inflammation 
during the follow-up period (Fig. 6, below).
DISCUSSION
Surgical closure of a cleft palate is intended 
to establish an intact separation between the oral 
and nasal cavities. Because of frequent limitations 
in the amount of local tissues and scarring after 
previous surgical procedures, the formation of an 
oronasal fistula is a common complication.27 Prog-
nosis for successful closure declines with further 
attempts at surgical correction.28 A multitude of 
closure techniques have been suggested, such as 
mucoperiosteal flaps,29 pedicled tongue flaps,30 
and free flaps,20 but many methods can cause 
donor-site morbidity.21,31
The use of an external biomaterial might rep-
resent one way to preserve healthy tissue without 
the limitations in local quantity and restrictions 
caused by cicatrization. Donor-site morbidity can 
be avoided by the use of alternative biological 
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materials. Biomaterials have become popular in 
head and neck reconstructive surgery, but only a 
few publications report their use in oronasal fis-
tula closure.
Acellular dermal matrices were introduced for 
the closure of palatal clefts in 2003.32 Kirschner et 
al.21 described oronasal fistula repair with acellu-
lar dermal matrices. In a swine model in the first 
part of the study and in a clinical trial with nine 
patients in the second part, the authors achieved 
convincing results. Complete fistula closure was 
observed in all patients, despite two patients ini-
tially presenting with a dehiscence. Aldekhayel 
et al.33 investigated the available evidence for 
the usage of acellular dermal matrix in cleft pal-
ate repair. The authors concluded that the use of 
acellular dermal matrices may reduce fistula for-
mation and fistula persistence in palate surgery, 
Fig. 7. Postoperative course after palatoplasty in the palate of piglets. Results 
on postoperative days 3 (left column) and 76 (right column). (Above) Amniotic 
membrane (AM) allograft used as the reconstruction material. Complete clo-
sure of oral epithelium of the iatrogenic oronasal fistula was observed in all 
animals by day 76. (Center) The same results were observed in the animals 
treated with autofetal amniotic membrane. (Below) Small intestinal submu-
cosa (SIS) as the transplanted material showed a persistent oronasal fistula in 
one of the animals.
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but they pointed out that prospective, random-
ized studies are necessary.
Ophof et al. investigated other biomateri-
als for the reconstruction of palatal defects in 
dogs, such as tissue-engineered mucosal sub-
stitutes containing oral keratinocytes34 or scaf-
folds of cross-linked bovine tendon collagen and 
glycosaminoglycans.35 Transplant loss and cell 
degradation were observed in the former study.
Amniotic membrane is currently used for 
reconstruction of the ocular surface,36 abdominal 
wall,26 urinary bladder,37 leg ulcers,38 and burns.39 
It exhibits anti-inflammatory effects and has low 
immunogenicity.40 This study reports the first 
Fig. 8. Chart visualizing the mean values of the clinically observed signs of inflammation (0, none; 1, moderate; 
2, pronounced) after palatoplasty with amniotic membrane (AM) allograft, autofetal amniotic membrane, or 
small intestinal submucosa (SIS). The axis of the ordinates shows the mean degree of local redness in all animals 
of a group. The axis of the abscissas displays postoperative days (POD) 3, 7, 10, and 76. Although no statistical 
analysis was carried out because of the small sample size, the diagram indicates that no clinically relevant dif-
ference was present in the rate of infections among the groups with amniotic membrane allograft, autofetal 
amniotic membrane (which showed exactly the same postoperative course with respect to local redness), and 
small intestinal submucosa, although the local signs of inflammation were slightly higher in the small intestinal 
submucosa group on postoperative days 3 and 10.
Fig. 9. Fistula tract residue (indicated by box) with mild chronic inflammation after oronasal 
fistula closure with autofetal amniotic membrane. Transverse section through former pala-
tine defect (hematoxylin and eosin stain).
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clinical use of amniotic membrane allografts and 
autofetal amniotic membrane for oronasal fistula 
repair. Complete fistula closure was observed after 
transplantation of multilayered autofetal amniotic 
membrane or amniotic membrane allograft in the 
animal experiment. No relevant immune reaction 
or reduced signs of inflammation compared with 
the group treated with small intestinal mucosa 
were noted on postoperative days 3 and 10.
The treatment of patients with amniotic 
membrane gave excellent results: all fistulas were 
closed with no signs of inflammation. The results 
demonstrate that transplantation of autofetal 
amniotic membrane or amniotic membrane 
allografts represents an interesting new method for 
oronasal fistula closure. A potential disadvantage 
might be the need to fabricate protective plates 
in order to avoid mechanical damage, but their 
use and the multilayer technique have solved 
the previously reported problem of mechanical 
instability of amniotic membrane.37 This study 
has demonstrated that the stability of an amniotic 
membrane transplant can be increased by using 
additional layers.
One interesting opportunity is the storage of 
autofetal amniotic membrane. Children who are 
prenatally diagnosed with a cleft palate can later 
be treated with their own amniotic membrane. 
Oronasal fistulas are usually not repaired dur-
ing the infant stage, but cryoconserved amniotic 
membrane can be stored and later used as an 
exclusive biomaterial for reconstructive surgery. 
It can also be used in case of burn wounds or 
other trauma. The procedures for harvesting and 
cryoconservation and the clinical use of autofetal 
amniotic membrane are offered to parents expect-
ing a child diagnosed with a cleft palate.
A drawback of this study is the small number 
of clinical cases. However, the results of the first 
patients treated with this method emphasize the 
encouraging findings from the earlier experimen-
tal study arm. A randomized trial with a larger 
number of cases is necessary to validate these ini-
tial results.
CONCLUSIONS
Amniotic membrane is useful for oronasal 
fistula repair. It prevents donor-site morbidity 
and is easy to harvest, economically reasonable, 
and available in large quantities. The multilayer 
technique and protective plates solve the prob-
lem of mechanical instability. It is now possible 
to harvest and store the autofetal amniotic mem-
brane of a child with a cleft palate as an exclusive 
tissue source for later reconstruction. Amniotic 
membrane allografts can be used without notice-
able disadvantages when compared with autofe-
tal amniotic membrane, which is relevant for 
patients with no reserves of autofetal amniotic 
membrane.
Marco R. Kesting, M.D., D.D.S., Ph.D.





Table 1. Results of Histologic Analysis of Palates on Day 76 after Oronasal Fistula Repair
Animal No. Oral Defect Nasal Defect Left Side Nasal Defect Right Side Inflammation Fibrosis
Oral fistulas repaired with amniotic membrane allograft
 1 – – – – +
 2 – – – – –
 3 – + – + –
 4 – + +++ – +
 5 – + + + +
 6 – – +++ + +
Oral fistulas repaired with autofetal amniotic membrane
 7 – +++ – + +
 8 – +++ – + +
 9 – – – – –
 10 – + – + –
 11 – – – – –
 12 – – – – +
Oral fistulas repaired with small intestinal submucosa
 13 – – + – –
 14 + ++ +++ – –
 15 – +++ + – +
 16 – + ++ + +
 17 – – +++ + +
 18 – + + + +
Symbols: –, negative; +, positive; ++, pronounced; +++, intensive.
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